原发性开角型青光眼治疗进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Progress on diagnosis and treatment of primary open angle glaucoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    既往流行病学结果证明,除白内障以外,青光眼是世界第二大主要的致盲眼病,其中原发性开角型青光眼发病率高,发病机制复杂多样,且发展缓慢,病情隐匿,早期大多数无明显症状,大多数患者就诊时已进入中晚期,出现了不可逆的视功能损伤,对家庭、社会危害极大。因此,早发现、早治疗,防止视功能的进一步损伤是开角型青光眼防治的重中之重。近年来该病患病率在临床上所占的比例逐年上升,相应的诊断及治疗的新方法层出不穷。然而不论早期或是中晚期患者,降低眼压、将眼压控制在目标眼压范围,延缓视功能损害依旧是治疗的最终目标,本文将对近年来对原发性青光眼的诊疗现状及进展做一综述。

    Abstract:

    As past epidemiological results show, in addition to cataract, glaucoma is the second major cause of blindness in the world. Among them, primary open angle glaucoma is with high incidence, low and unobvious development. Its cause and pathogenesis is complex and diverse. In the early stage, most patients have no obvious symptoms. Most of them have entered middle or late stage when they visit the doctor and the visual impairment is irreversible, which extremely harm the family and the society. Therefore, early detection and treatment is the first priority to prevent further damage to visual function in patients with glaucoma. In recent years, with the proportion of the disease increasing year by year, new methods of diagnosis and treatment is one after another. But whether in early or late stage, reducing the intraocular pressure(IOP), keeping it in the target IOP range and delaying the visual impairment are still the ultimate goal of treatments. This test will be a summary of the diagnosis and treatment of primary open angle glaucoma based on the relevant literature in recent years.

    参考文献
    相似文献
    引证文献
引用本文

任霞,贺经,冯延琴.原发性开角型青光眼治疗进展.国际眼科杂志, 2016,16(3):458-461.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2015-11-17
  • 最后修改日期:2016-02-18
  • 录用日期:
  • 在线发布日期: 2016-03-02
  • 出版日期:
文章二维码